Autoliv, Inc. — Q1 2012 Form 10-Q
Business context and period: Quarterly report for the three months ended March 31, 2012. Autoliv supplies automotive safety systems, including airbags, seatbelts, and active safety products, to global vehicle manufacturers.
Financial performance
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Net sales | $2,178.9 million | $2,108.6 million |
| Gross profit / margin | $441.1 million / 20.2% | $466.0 million / 22.1% |
| Operating income / margin | $153.3 million / 7.0% | $254.8 million / 12.1% |
| Net income attributable to controlling interest | $100.5 million | $181.5 million |
| Diluted EPS | $1.07 | $1.93 |
| Operating cash flow | $98.0 million | $141.4 million |
- Reported sales rose 3.3%; organic sales grew 5.0%, while currency reduced sales by $32.6 million. Active safety sales rose 29% to $48 million.
- Gross margin fell 1.9 percentage points. Management cited $15 million of higher raw-material costs, adverse sales mix, Europe’s production decline, and ramp-up costs in North America and China.
- Operating income fell $101.5 million. Management cited $47 million more capacity-alignment costs, $12 million higher net R&D expense, and a $14.5 million accrual for the U.S. Department of Justice (DOJ) antitrust investigation.
- Net investing cash outflow was $78.8 million, including $79.5 million of capital expenditures. Operating cash flow less investing outflow was $19 million, versus $63 million a year earlier.
- Cash was $732.0 million; total debt was $678.0 million, leaving $66.9 million of net cash after debt-related derivatives. Current assets were $3,195.7 million and current liabilities $2,128.4 million.
- Compared with December 31, 2011, short-term debt declined to $209.3 million from $302.8 million, while long-term debt rose to $468.7 million from $363.5 million. Cash declined by $7.2 million during the quarter.
Changes, outlook, and risks
- Autoliv reported Q1 organic sales growth despite an estimated nearly 5% decline in European vehicle production. Sales benefited from strong activity in the Americas and Japan, and market-share gains in China.
- Operating performance was burdened by $48 million of capacity-alignment costs. Restructuring reserves increased to $79.0 million, primarily from employee-related actions in Europe; management said it did not expect these programs to materially harm liquidity.
- Management forecast Q2 2012 sales growth of 3% reported and approximately 7% organic, reflecting an expected 4% negative currency effect. For full-year 2012, it indicated approximately 4% reported sales growth, 7% organic growth, and a 10–11% operating margin. Margin guidance excludes capacity-alignment and antitrust costs; expected full-year capacity-alignment costs were $60–80 million.
- Management expected full-year operating cash flow of approximately $700 million, excluding antitrust payments; capital expenditures were expected to be approximately 4.5% of sales. The projected tax rate for the remainder of 2012 was approximately 27%, excluding discrete items.
- The DOJ investigation remained ongoing; Autoliv accrued $14.5 million for its estimated resolution, but the final amount could differ. The European Commission investigation was also ongoing, with no loss provision recorded because the impact could not be estimated; the filing says a material adverse effect on results and cash flows is probable when liabilities become estimable or the matter is resolved.
- Other disclosed exposures include product warranty, recall, and liability claims; intellectual-property claims; and French labor and liquidation proceedings. Management reported no material change in contractual obligations or market-risk disclosures, and no material off-balance-sheet arrangements.
- The March 2012 remarketing reset the coupon on the 2014 senior notes to 3.854%; Autoliv expected about $11 million of 2012 interest savings. It also extended essentially all of its $1.1 billion revolving credit facility to April 2017.
Important facts for investors to verify
- Progress and final financial consequences of the DOJ and European Commission antitrust investigations, including potential cash payments beyond the DOJ accrual.
- Whether projected organic growth and 10–11% full-year operating margin are achieved, noting that margin guidance excludes capacity-alignment and antitrust costs.
- Whether restructuring costs, raw-material inflation, production mix, and regional vehicle-production trends continue to pressure margins.
- Cash generation, capital spending, working-capital trends, and the effect of the equity-unit settlement, which was expected to issue approximately 5.8 million shares on April 30, 2012.
- Developments in product-related liabilities and the disclosed French proceedings; the filing states that outcomes of litigation cannot be assured.